Covid-19 Antigen Rapid Lateral Flow Test Nasal Sample
For more information or to place your order, contact info@itstestkits.com
- Results in 15 minutes
- Aids identification of a current infection
- Nasopharyngeal swab sample required
- CE Marked for professional use only
- Cost effective screening tool
- Easy to use
The Rapid Lateral Flow COVID-19 Antigen Test is an in vitro Immunochromatographic assay for the qualitative detection of nucleocapsid protein antigens from COVID-19 (SARS-CoV-2) in human nasal (nose) samples.
Our COVID-19 Antigen Test is one of the world’s first rapid screening tests for the identification of COVID-19 (SARS-CoV-2), following initial exposure to the virus and or after the onset of symptoms.
There is no laboratory testing required, instead screening results are available in just 15 minutes via the point of care rapid test cassette.
Implementing rapid screening for COVID-19 (SARS-CoV-2), has huge time and cost savings when compared to, or integrated into, laboratory screening and will help to control the spread of the virus, by identifying active infection rapidly and accurately.
How do I understand the Antigen results?
A total of two detection lines are possible. The control (C) line appears when the sample flows through the testing device cassette, after the buffer liquid containing the sample has been added.
Negative Result
The test result is negative if only the quality control line (C) appears. This means no COVID-19 specific antigens have been detected.
Positive Result
The test result is positive if the quality control line (C) and the antigen detection line (T) appears. This means COVID-19 specific antigens have been detected.
Where this is the case, the tested individual and the healthcare provider must follow the latest government guidance on both result reporting, quarantining and self-isolation.
Please see our Product & User Guide on the Training section of our website.
For more information or to place your order, contact info@itstestkits.com